Both ERK/MAPK and TGF-Beta/Smad Signaling Pathways Play a Role in the Kidney Fibrosis of Diabetic Mice Accelerated by Blood Glucose Fluctuation
Open Access
- 31 December 2012
- journal article
- research article
- Published by Hindawi Limited in Journal of Diabetes Research
- Vol. 2013, 1-8
- https://doi.org/10.1155/2013/463740
Abstract
Background. The notion that diabetic nephropathy is the leading cause of renal fibrosis prompted us to investigate the effects of blood glucose fluctuation (BGF) under high glucose condition on kidney in the mice. Methods. The diabetic and BGF animal models were established in this study. Immunohistochemistry, Western blot, and RT-PCR analysis were applied to detect the expression of type I collagen, matrix metalloproteinase-1 (MMP1), metalloproteinase inhibitor 1 (TIMP1), transforming growth factor beta 1 (TGF-beta 1), phosphorylated-ERK, p38, smad2/3, and Akt. Results. BGF treatment increased type I collagen synthesis by two times compared with the control. The expression of MMP1 was reduced markedly while TIMP1 synthesis was enhanced after BGF treatment. ERK phosphorylation exhibits a significant increase in the mice treated with BGF. Furthermore, BGF can markedly upregulate TGF-beta 1 expression. The p-smad2 showed 2-fold increases compared with the only diabetic mice. However, p-AKT levels were unchanged after BGF treatment. Conclusions. These data demonstrate that BGF can accelerate the trend of kidney fibrosis in diabetic mice by increasing collagen production and inhibiting collagen degradation. Both ERK/MAPK and TGF-beta/smad signaling pathways seem to play a role in the development of kidney fibrosis accelerated by blood glucose fluctuation.Funding Information
- National Basic Research Program of China (2012CB910400, 81272226, 2010CB945400)
This publication has 27 references indexed in Scilit:
- The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic PotentialDiabetes, 2011
- Effects of blood glucose fluctuation on skin biophysical properties, structure and antioxidant status in an animal modelClinical and Experimental Dermatology, 2010
- Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivoAmerican Journal of Physiology-Renal Physiology, 2008
- Mutant p53 Attenuates the SMAD-Dependent Transforming Growth Factor β1 (TGF-β1) Signaling Pathway by Repressing the Expression of TGF-β Receptor Type IIMolecular and Cellular Biology, 2007
- Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproductionDiabetes/Metabolism Research and Reviews, 2006
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposureAmerican Journal of Physiology-Renal Physiology, 2004
- Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymeraseJournal of Thrombosis and Haemostasis, 2004
- In search of normoglycaemia in diabetes: controlling postprandial glucoseInternational Journal of Obesity, 2002
- The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complicationsDiabetic Medicine, 1998